Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Shepherd

Showing results (751-760 of 1,262) with videos related to

Pageof 127
Sort By:
Metabolism: Clinical and Experimental|March 1, 1980
Apolipoprotein B metabolism in normal, type IV and type V hyperlipoproteinemic subjectsC J Packard, J Shepherd, S Joerns, et al.
Human Antibodies and Hybridomas|October 1, 1992
Susceptibility of human monoclonal antibody-producing B cell lines to infection by human immunodeficiency virusA J Shepherd, J E Boyd, C L Hogg, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1996
Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindredJ R Burgess, J J Shepherd, V Parameswaran, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1996
Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: clinical features and inheritance patternJ R Burgess, J J Shepherd, V Parameswaran, et al.
Transgenic Research|March 1, 1997
Promoter/leader deletion analysis and plant expression vectors with the figwort mosaic virus (FMV) full length transcript (FLt) promoter containing single or double enhancer domainsI B Maiti, S Gowda, J Kiernan, et al.
Current Opinion in Systems Biology|April 3, 2023
Germline immunoglobulin genes: disease susceptibility genes hidden in plain sight?Andrew M Collins, Gur Yaari, Adrian J Shepherd, et al.
The New England Journal of Medicine|May 29, 1980
Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolismJ Shepherd, C J Packard, S Bicker, et al.
Plos One|December 31, 2015
Relationships between Psychosocial Resilience and Physical Health Status of Western Australian Urban Aboriginal YouthKatrina D Hopkins, Carrington C J Shepherd, Catherine L Taylor, et al.
Journal of Lipid Research|September 1, 1986
Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjectsC J Packard, R J Clegg, M H Dominiczak, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
High-dose cyclophosphamide followed by cisplatinum in the treatment of ovarian cancerR Osborne, B Evans, C Gallagher, et al.
Pageof 127

Showing results (751-760 of 1,262) with videos related to

Sort By:
Pageof 127
Metabolism: Clinical and Experimental|March 1, 1980
Apolipoprotein B metabolism in normal, type IV and type V hyperlipoproteinemic subjectsC J Packard, J Shepherd, S Joerns, et al.
Human Antibodies and Hybridomas|October 1, 1992
Susceptibility of human monoclonal antibody-producing B cell lines to infection by human immunodeficiency virusA J Shepherd, J E Boyd, C L Hogg, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1996
Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindredJ R Burgess, J J Shepherd, V Parameswaran, et al.
The Journal of Clinical Endocrinology and Metabolism|May 1, 1996
Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: clinical features and inheritance patternJ R Burgess, J J Shepherd, V Parameswaran, et al.
Transgenic Research|March 1, 1997
Promoter/leader deletion analysis and plant expression vectors with the figwort mosaic virus (FMV) full length transcript (FLt) promoter containing single or double enhancer domainsI B Maiti, S Gowda, J Kiernan, et al.
Current Opinion in Systems Biology|April 3, 2023
Germline immunoglobulin genes: disease susceptibility genes hidden in plain sight?Andrew M Collins, Gur Yaari, Adrian J Shepherd, et al.
The New England Journal of Medicine|May 29, 1980
Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolismJ Shepherd, C J Packard, S Bicker, et al.
Plos One|December 31, 2015
Relationships between Psychosocial Resilience and Physical Health Status of Western Australian Urban Aboriginal YouthKatrina D Hopkins, Carrington C J Shepherd, Catherine L Taylor, et al.
Journal of Lipid Research|September 1, 1986
Effects of bezafibrate on apolipoprotein B metabolism in type III hyperlipoproteinemic subjectsC J Packard, R J Clegg, M H Dominiczak, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
High-dose cyclophosphamide followed by cisplatinum in the treatment of ovarian cancerR Osborne, B Evans, C Gallagher, et al.
Pageof 127